Yuki Funauchi

653 total citations
32 papers, 406 citations indexed

About

Yuki Funauchi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Yuki Funauchi has authored 32 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 13 papers in Rheumatology. Recurrent topics in Yuki Funauchi's work include Sarcoma Diagnosis and Treatment (20 papers), Bone Tumor Diagnosis and Treatments (6 papers) and Vascular Tumors and Angiosarcomas (5 papers). Yuki Funauchi is often cited by papers focused on Sarcoma Diagnosis and Treatment (20 papers), Bone Tumor Diagnosis and Treatments (6 papers) and Vascular Tumors and Angiosarcomas (5 papers). Yuki Funauchi collaborates with scholars based in Japan, United States and Netherlands. Yuki Funauchi's co-authors include Chizu Tanikawa, Koichi Matsuda, Jinichi Mori, Yusuke Nakamura, Keisuke Ae, Seiichi Matsumoto, Paulisally Hau Yi Lo, Taisuke Tanizawa, Keiko Hayakawa and Atsushi Okawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Scientific Reports.

In The Last Decade

Yuki Funauchi

27 papers receiving 403 citations

Peers

Yuki Funauchi

PRM

ONCOL

RHEUM

Jingnan Shen China

Elisa Pastore Italy

Akihiro Hemmi Japan

Sung Wook Seo South Korea

Shridevi Karikehalli United States

Toru Morishita Japan

Duygu Gürel Türkiye

V. Kannan India

Anastasios Kyriazoglou Greece

Hiromasa Fujii Japan

Jingnan Shen China

Yuki Funauchi

149 ×0.9

PRM

93 ×0.6

ONCOL

150 ×1.2

100 ×1.1

RHEUM

50 ×0.7

Citations per year, relative to Yuki Funauchi Yuki Funauchi (= 1×) peers Jingnan Shen

Countries citing papers authored by Yuki Funauchi

Since Specialization

Citations

This map shows the geographic impact of Yuki Funauchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Funauchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Funauchi more than expected).

Fields of papers citing papers by Yuki Funauchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Funauchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Funauchi. The network helps show where Yuki Funauchi may publish in the future.

Co-authorship network of co-authors of Yuki Funauchi

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Funauchi. A scholar is included among the top collaborators of Yuki Funauchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Funauchi. Yuki Funauchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ishibashi, Hironori, et al.. (2024). Excision of Giant Chronic Expanding Hematoma of the Thorax Caused by Rib Fractures after Proton Radiotherapy for Lung Cancer. Annals of Thoracic and Cardiovascular Surgery. 30(1). n/a–n/a.

Takagi, Satoshi, Sumie Koike, Miho Takami, et al.. (2024). Frequent copy number gain of MCL1 is a therapeutic target for osteosarcoma. Oncogene. 44(12). 794–804.

Funauchi, Yuki, Satoshi Tsukushi, Hiroaki Hiraga, et al.. (2024). Study protocol: randomized phase III trial of neo-adjuvant and adjuvant chemotherapy vs. immediate surgery and adjuvant chemotherapy for localized soft tissue sarcoma: Japan Clinical Oncology Group study JCOG2102 (NACLESS). Japanese Journal of Clinical Oncology. 55(3). 297–303.

Takemoto, Ai, Satoshi Takagi, Nobuhiko Gyobu, et al.. (2022). Targeting Podoplanin for the Treatment of Osteosarcoma. Clinical Cancer Research. 28(12). 2633–2645. 19 indexed citations

Takagi, Satoshi, Sumie Koike, Ai Takemoto, et al.. (2021). Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis. Oncogene. 40(36). 5548–5558. 33 indexed citations

Sato, Yasuyoshi, Kenji Nakano, Xiaofei Wang, et al.. (2021). Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma. Cancers. 13(24). 6266–6266. 10 indexed citations

Matsumoto, Seiichi, Keisuke Ae, Taisuke Tanizawa, et al.. (2021). Surgical Treatment of Intramuscular Myxoma. Indian Journal of Orthopaedics. 55(4). 892–897. 6 indexed citations

Yamashita, Kyoko, Yuki Funauchi, Keiko Hayakawa, et al.. (2021). S100-negative epithelioid malignant peripheral nerve sheath tumor with possible perineurial differentiation. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 480(6). 1269–1275. 4 indexed citations

Sato, Yasuyoshi, Kenji Nakano, Naoki Fukuda, et al.. (2021). Pre-treatment Neutrophil-to-Lymphocyte Ratio Predicts Efficacy of Eribulin for Soft-tissue Sarcoma. Anticancer Research. 41(1). 527–532. 7 indexed citations

10.

Nakano, Kenji, Keiko Hayakawa, Yuki Funauchi, et al.. (2020). Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line. Molecular and Clinical Oncology. 14(1). 13–13. 6 indexed citations

11.

Hayakawa, Keiko, Seiichi Matsumoto, Keisuke Ae, et al.. (2020). Definitive surgery of primary lesion should be prioritized over preoperative chemotherapy to treat high-grade osteosarcoma in patients aged 41–65 years. Journal of Orthopaedics and Traumatology. 21(1). 13–13. 9 indexed citations

12.

Matsumoto, Seiichi, Keisuke Ae, Taisuke Tanizawa, et al.. (2020). The Role of Neoadjuvant Chemotherapy in Resectable Primary Synovial Sarcoma. Anticancer Research. 40(2). 1029–1034. 8 indexed citations

13.

Nakano, Kenji, Yuki Funauchi, Keiko Hayakawa, et al.. (2019). Relative Dose Intensity of Induction-Phase Pazopanib Treatment of Soft Tissue Sarcoma: Its Relationship with Prognoses of Pazopanib Responders. Journal of Clinical Medicine. 8(1). 60–60. 11 indexed citations

14.

Matsumoto, Seiichi, Keisuke Ae, Taisuke Tanizawa, et al.. (2018). Successful Complete Response of Tumor Thrombus after Combined with Chemotherapy and Irradiation for Ewing Sarcoma. SHILAP Revista de lepidopterología. 2018(1). 5238512–5238512. 2 indexed citations

15.

Kito, Munehisa, Seiichi Matsumoto, Keisuke Ae, et al.. (2018). Giant cell tumor of the distal femur: Outcome beyond 20 years of follow-up after curettage with polymethylmethacrylate. Journal of Orthopaedic Science. 23(6). 1051–1055. 4 indexed citations

16.

Kito, Munehisa, Seiichi Matsumoto, Keisuke Ae, et al.. (2017). Multicentric giant cell tumor of bone: Case series of 4 patients. Journal of Orthopaedic Science. 22(6). 1107–1111. 1 indexed citations

17.

Tanikawa, Chizu, Yaozhong Zhang, Yusuke Tsuda, et al.. (2017). The Transcriptional Landscape of p53 Signalling Pathway. EBioMedicine. 20. 109–119. 56 indexed citations

18.

Mori, Jinichi, Chizu Tanikawa, Naomi Ohnishi, et al.. (2017). EPSIN 3, A Novel p53 Target, Regulates the Apoptotic Pathway and Gastric Carcinogenesis. Neoplasia. 19(3). 185–195. 13 indexed citations

19.

Hayakawa, Keiko, Seiichi Matsumoto, Keisuke Ae, et al.. (2016). Risk factors for distant metastasis of dermatofibrosarcoma protuberans. Journal of Orthopaedics and Traumatology. 17(3). 261–266. 27 indexed citations

20.

Funauchi, Yuki, Chizu Tanikawa, Paulisally Hau Yi Lo, et al.. (2015). Regulation of iron homeostasis by the p53-ISCU pathway. Scientific Reports. 5(1). 16497–16497. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact